Gastroenterology Research and Practice / 2016 / Article / Tab 4

Research Article

Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience

Table 4

Intervention modalities at different stages.

1st intervention ()2nd intervention ()3rd intervention ()4th intervention ()5th intervention ()

TACE17.40%35.20%44.20%53.80%53.80%
TARE4.30%5.70%7%7.70%0.00%
RFA16.20%13.6%11.60%3.80%0.00%
PEI11.50%13.6%18.6%19.20%7.70%
Resection3.80%2.30%0.00%0.00%0.00%
Transplant1.30%13.6%11.60%0.00%7.70%
Sorafenib8.50%2.30%7%0.00%23.10%
Best supportive care37%13.60%0.00%15.40%7.70%

TACE: transarterial chemoembolization; TARE: transarterial radioembolization; RFA: radiofrequency ablation; PEI: percutaneous ethanol injection.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.